JW Asset Management, LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 325 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.44 and the average weighting 0.4%.

Quarter-by-quarter ownership
JW Asset Management, LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$1,819,000
-50.5%
13,4010.0%1.34%
-32.5%
Q3 2018$3,678,000
+32.5%
13,4010.0%1.98%
+12.1%
Q2 2018$2,776,000
+25.4%
13,4010.0%1.77%
-18.8%
Q1 2018$2,213,000
+20.6%
13,4010.0%2.18%
+11.7%
Q4 2017$1,835,000
+0.5%
13,4010.0%1.95%
+46.0%
Q3 2017$1,825,000
+12.2%
13,4010.0%1.34%
+29.1%
Q2 2017$1,627,000
-11.7%
13,401
-23.0%
1.04%
+170.5%
Q1 2017$1,842,000
-49.8%
17,401
-51.8%
0.38%
-84.3%
Q4 2016$3,667,000
-16.8%
36,086
-16.4%
2.44%
-19.6%
Q3 2016$4,406,000
+2.1%
43,174
+19.4%
3.03%
-11.5%
Q2 2016$4,314,000
+11.4%
36,1740.0%3.43%
+35.5%
Q1 2016$3,874,000
-1.2%
36,1740.0%2.53%
+72.9%
Q4 2015$3,922,000
+26.6%
36,1740.0%1.46%
+30.4%
Q3 2015$3,098,000
-14.3%
36,174
+0.9%
1.12%
+2.1%
Q2 2015$3,616,000
+33.9%
35,838
+2.3%
1.10%
-5.9%
Q1 2015$2,700,000
+55.1%
35,019
+7.0%
1.17%
-10.6%
Q4 2014$1,741,00032,7271.31%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Knott David M Jr 115,000$12,937,0004.12%
Stonepine Capital Management, LLC 73,700$8,291,0003.44%
VILLERE ST DENIS J & CO LLC 510,843$57,464,0003.41%
Chicago Capital, LLC 491,717$55,313,0002.38%
Orchard Capital Management, LLC 73,596$8,279,0002.35%
RICE HALL JAMES & ASSOCIATES, LLC 344,969$38,806,0001.55%
Smith, Graham & Co., Investment Advisors, LP 86,834$9,768,0001.02%
WOODSTOCK CORP 64,050$7,205,0000.84%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 37,246$4,190,0000.74%
Stephens Investment Management Group LLC 417,670$46,984,0000.69%
View complete list of LIGAND PHARMACEUTICALS INC shareholders